Michael J. Farrell - 16 Nov 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
16 Nov 2022
Transactions value $
$8,212,666
Form type
4
Filing time
18 Nov 2022, 18:55:16 UTC
Previous filing
16 Nov 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RMD ResMed Common Stock 3.88K 16 Nov 2022 Lisette & Michael Farrell Family Foundation
holding RMD ResMed Common Stock 414K 16 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $8.21M +36.6K $224.58 36.6K 16 Nov 2022 ResMed Common Stock 36.6K $224.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.